Androgen replacement therapy

Drug Profile

Androgen replacement therapy

Alternative Names: Andrin; Dihydrotestosterone transdermal gel - ASCEND

Latest Information Update: 04 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Besins International
  • Developer ASCEND Therapeutics
  • Class Androstanols; Testosterone congeners
  • Mechanism of Action Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Benign prostatic hyperplasia; Hypogonadism

Most Recent Events

  • 14 Nov 2006 DHT gel is still in phase II trials for Hypogonadism in USA
  • 29 Oct 2004 Phase-II clinical trials in Hypogonadism in USA (Transdermal)
  • 16 Jul 2004 Phase-II clinical trials in Benign prostatic hyperplasia in Australia (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top